Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by GameChangerBeton Jul 03, 2021 4:25pm
230 Views
Post# 33489921

RE:RE:RE:RE:RE:RE:RE:RE:What exactly is antibe royalty shares

RE:RE:RE:RE:RE:RE:RE:RE:What exactly is antibe royalty shares

Mugs, the fact of the matter is that some of these folks are not interested in genuine dialogue.
There's no need to believe anything, if someone posts something, all you have to do is literally copy the post into an email and send it off to the company to fact check the accuracy of the information.
They won't put in 2 seconds of work for their investment, they'd rather troll around and cause a disturbance.
 

MrMugsy wrote: StockingUp ... in general ... some people here go the extra mile and ask  management questions.  Therefore, some do get tidbits that others don't get.

I wouldn't call it a crime nor would I want them to stop asking questions.

That's the benefit of social media.  Regardless, you still have to be careful about what you decide to believe.

For example ... I'm going to believe that we get an update from Dan around mid-July.  You don't have to believe it.  But if people hear something, and share it, you should be thankful ... and not upset about it.  If it hapens, it happens.  If it doesn't, it doesn't.  That's how it works around here.



 

<< Previous
Bullboard Posts
Next >>